
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.15 | 0.15 | 0.00 |
Stocks | 97.23 | 97.23 | 0.00 |
Other | 2.62 | 2.80 | 0.18 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.94 | 19.58 |
Price to Book | 4.99 | 4.48 |
Price to Sales | 3.73 | 2.54 |
Price to Cash Flow | 14.54 | 17.39 |
Dividend Yield | 1.03 | 1.09 |
5 Years Earnings Growth | 15.90 | 12.01 |
Number of long holdings: 185
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 14.25 | 204.27 | -0.97% | |
Amgen | US0311621009 | 7.85 | 305.44 | -0.48% | |
Krystal Biotech | US5011471027 | 6.97 | 179.59 | +2.87% | |
Vertex | US92532F1003 | 5.08 | 485.09 | +0.07% | |
Alnylam | US02043Q1076 | 4.38 | 265.10 | +3.65% | |
Gilead | US3755581036 | 3.74 | 111.24 | -0.04% | |
argenx ADR | US04016X1019 | 2.62 | 578.60 | +2.03% | |
UCB | BE0003739530 | 2.42 | 162.70 | -0.61% | |
Regeneron Pharma | US75886F1075 | 2.19 | 626.25 | +1.50% | |
Ascendis Pharma AS | US04351P1012 | 2.00 | 154.31 | +1.90% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 597.55B | 1.44 | 12.54 | 12.97 | ||
Fidelity Contrafund | 133.27B | 3.52 | 17.24 | 15.17 | ||
Fidelity Contrafund K | 11.68B | 3.55 | 17.32 | 15.27 | ||
Fidelity Total Market Index Instl b | 100.03B | 1.12 | 11.54 | 12.30 | ||
Fidelity Blue Chip Growth | 54.94B | -2.84 | 15.11 | 17.11 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review